North America Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software and Services), By End-use, By Deployment, By Application, By Country and Growth Forecast, 2024 - 2031
Published Date : 09-Sep-2024 |
Pages: 127 |
Formats: PDF |
COVID-19 Impact on the North America Clinical Risk Grouping Solution Market
Market Overview
The North America Clinical Risk Grouping Solution Market would witness market growth of 12.4% CAGR during the forecast period (2024-2031).
The US market dominated the North America Clinical Risk Grouping Solution Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $489.8 million by 2031. The Canada market is experiencing a CAGR of 14.8% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 13.9% during (2024 - 2031).
A clinical risk grouping solution is a healthcare technology tool designed to categorize or "group" patients based on their risk of experiencing certain health outcomes, such as complications, hospitalizations, or the progression of chronic diseases.
Additionally, these solutions use various data inputs, including electronic health records (EHRs), claims data, demographic information, and sometimes social determinants of health, to analyze and stratify patients according to their risk levels.
North American healthcare providers are increasingly adopting these solutions to enhance patient outcomes, reduce healthcare costs, and comply with government regulations. Furthermore, the growing incidence of chronic diseases in the United States is a significant factor that is driving the demand for clinical risk classification systems. According to the Centers for Disease Control and Prevention (CDC), chronic disease affects 6 in 10 adults in the US, while 4 in 10 adults live with multiple chronic diseases. Chronic diseases represent one of the nation’s leading causes of disability and drivers of the nation’s $4.1 trillion in annual healthcare spending.
Free Valuable Insights: The Clinical Risk Grouping Solution Market is Predict to reach USD 1.7 Billion by 2031, at a CAGR of 12.9%
Based on Product, the market is segmented into Software and Services. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Long Term Care Centers, and Other. Based on Deployment, the market is segmented into Private Cloud, Public Cloud, and Hybrid Cloud. Based on Application, the market is segmented into Population Health Management, Chronic Disease Management, Clinical Decision Support, Fraud Detection and Prevention, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Conduent, Incorporated
- 3M Company
- Oracle Corporation (Cerner Corporation)
- Microsoft Corporation (Nuance Communications, Inc.)
- Health Catalyst, Inc.
- Koninklijke Philips N.V.
- Siemens Healthineers AG (Siemens AG)
- HBI Solutions
- Lightbeam Health Solutions
- Reveleer
North America Clinical Risk Grouping Solution Market Report Segmentation
By Product
- Software
- Services
By End-use
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Long Term Care Centers
- Other
By Deployment
- Private Cloud
- Public Cloud
- Hybrid Cloud
By Application
- Population Health Management
- Chronic Disease Management
- Clinical Decision Support
- Fraud Detection and Prevention
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Clinical Risk Grouping Solution Market, by Product
1.4.2 North America Clinical Risk Grouping Solution Market, by End-use
1.4.3 North America Clinical Risk Grouping Solution Market, by Deployment
1.4.4 North America Clinical Risk Grouping Solution Market, by Application
1.4.5 North America Clinical Risk Grouping Solution Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities:
3.2.4 Market Challenges:
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2021, Mar – 2024, Apr) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. North America Clinical Risk Grouping Solution Market by Product
5.1 North America Software Market by Region
5.2 North America Services Market by Region
Chapter 6. North America Clinical Risk Grouping Solution Market by End-use
6.1 North America Hospitals & Clinics Market by Country
6.2 North America Ambulatory Surgical Centers Market by Country
6.3 North America Long Term Care Centers Market by Country
6.4 North America Other Market by Country
Chapter 7. North America Clinical Risk Grouping Solution Market by Deployment
7.1 North America Private Cloud Market by Country
7.2 North America Public Cloud Market by Country
7.3 North America Hybrid Cloud Market by Country
Chapter 8. North America Clinical Risk Grouping Solution Market by Application
8.1 North America Population Health Management Market by Country
8.2 North America Chronic Disease Management Market by Country
8.3 North America Clinical Decision Support Market by Country
8.4 North America Fraud Detection and Prevention Market by Country
8.5 North America Others Market by Country
Chapter 9. North America Clinical Risk Grouping Solution Market by Country
9.1 US Clinical Risk Grouping Solution Market
9.1.1 US Clinical Risk Grouping Solution Market by Product
9.1.2 US Clinical Risk Grouping Solution Market by End-use
9.1.3 US Clinical Risk Grouping Solution Market by Deployment
9.1.4 US Clinical Risk Grouping Solution Market by Application
9.2 Canada Clinical Risk Grouping Solution Market
9.2.1 Canada Clinical Risk Grouping Solution Market by Product
9.2.2 Canada Clinical Risk Grouping Solution Market by End-use
9.2.3 Canada Clinical Risk Grouping Solution Market by Deployment
9.2.4 Canada Clinical Risk Grouping Solution Market by Application
9.3 Mexico Clinical Risk Grouping Solution Market
9.3.1 Mexico Clinical Risk Grouping Solution Market by Product
9.3.2 Mexico Clinical Risk Grouping Solution Market by End-use
9.3.3 Mexico Clinical Risk Grouping Solution Market by Deployment
9.3.4 Mexico Clinical Risk Grouping Solution Market by Application
9.4 Rest of North America Clinical Risk Grouping Solution Market
9.4.1 Rest of North America Clinical Risk Grouping Solution Market by Product
9.4.2 Rest of North America Clinical Risk Grouping Solution Market by End-use
9.4.3 Rest of North America Clinical Risk Grouping Solution Market by Deployment
9.4.4 Rest of North America Clinical Risk Grouping Solution Market by Application
Chapter 10. Company Profiles
10.1 Conduent, Incorporated
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.2 3M Company
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Oracle Corporation (Cerner Corporation)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Microsoft Corporation (Nuance Communications, Inc.)
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent strategies and developments:
10.4.5.1 Product Launches and Product Expansions:
10.4.6 SWOT Analysis
10.5 Health Catalyst, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent strategies and developments:
10.5.5.1 Product Launches and Product Expansions:
10.5.5.2 Acquisition and Mergers:
10.5.6 SWOT Analysis
10.6 Koninklijke Philips N.V.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.6.5.2 Acquisition and Mergers:
10.6.6 SWOT Analysis
10.7 Siemens Healthineers AG (Siemens AG)
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 SWOT Analysis
10.8 HBI Solutions
10.8.1 Company Overview
10.9 Lightbeam Health Solutions
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:
10.9.2.2 Acquisition and Mergers:
10.10. Reveleer
10.10.1 Company Overview
10.10.2 Recent strategies and developments:
10.10.2.1 Acquisition and Mergers:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Clinical Risk Grouping Solution Market, by Product
1.4.2 North America Clinical Risk Grouping Solution Market, by End-use
1.4.3 North America Clinical Risk Grouping Solution Market, by Deployment
1.4.4 North America Clinical Risk Grouping Solution Market, by Application
1.4.5 North America Clinical Risk Grouping Solution Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities:
3.2.4 Market Challenges:
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2021, Mar – 2024, Apr) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. North America Clinical Risk Grouping Solution Market by Product
5.1 North America Software Market by Region
5.2 North America Services Market by Region
Chapter 6. North America Clinical Risk Grouping Solution Market by End-use
6.1 North America Hospitals & Clinics Market by Country
6.2 North America Ambulatory Surgical Centers Market by Country
6.3 North America Long Term Care Centers Market by Country
6.4 North America Other Market by Country
Chapter 7. North America Clinical Risk Grouping Solution Market by Deployment
7.1 North America Private Cloud Market by Country
7.2 North America Public Cloud Market by Country
7.3 North America Hybrid Cloud Market by Country
Chapter 8. North America Clinical Risk Grouping Solution Market by Application
8.1 North America Population Health Management Market by Country
8.2 North America Chronic Disease Management Market by Country
8.3 North America Clinical Decision Support Market by Country
8.4 North America Fraud Detection and Prevention Market by Country
8.5 North America Others Market by Country
Chapter 9. North America Clinical Risk Grouping Solution Market by Country
9.1 US Clinical Risk Grouping Solution Market
9.1.1 US Clinical Risk Grouping Solution Market by Product
9.1.2 US Clinical Risk Grouping Solution Market by End-use
9.1.3 US Clinical Risk Grouping Solution Market by Deployment
9.1.4 US Clinical Risk Grouping Solution Market by Application
9.2 Canada Clinical Risk Grouping Solution Market
9.2.1 Canada Clinical Risk Grouping Solution Market by Product
9.2.2 Canada Clinical Risk Grouping Solution Market by End-use
9.2.3 Canada Clinical Risk Grouping Solution Market by Deployment
9.2.4 Canada Clinical Risk Grouping Solution Market by Application
9.3 Mexico Clinical Risk Grouping Solution Market
9.3.1 Mexico Clinical Risk Grouping Solution Market by Product
9.3.2 Mexico Clinical Risk Grouping Solution Market by End-use
9.3.3 Mexico Clinical Risk Grouping Solution Market by Deployment
9.3.4 Mexico Clinical Risk Grouping Solution Market by Application
9.4 Rest of North America Clinical Risk Grouping Solution Market
9.4.1 Rest of North America Clinical Risk Grouping Solution Market by Product
9.4.2 Rest of North America Clinical Risk Grouping Solution Market by End-use
9.4.3 Rest of North America Clinical Risk Grouping Solution Market by Deployment
9.4.4 Rest of North America Clinical Risk Grouping Solution Market by Application
Chapter 10. Company Profiles
10.1 Conduent, Incorporated
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.2 3M Company
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Oracle Corporation (Cerner Corporation)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Microsoft Corporation (Nuance Communications, Inc.)
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent strategies and developments:
10.4.5.1 Product Launches and Product Expansions:
10.4.6 SWOT Analysis
10.5 Health Catalyst, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent strategies and developments:
10.5.5.1 Product Launches and Product Expansions:
10.5.5.2 Acquisition and Mergers:
10.5.6 SWOT Analysis
10.6 Koninklijke Philips N.V.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.6.5.2 Acquisition and Mergers:
10.6.6 SWOT Analysis
10.7 Siemens Healthineers AG (Siemens AG)
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 SWOT Analysis
10.8 HBI Solutions
10.8.1 Company Overview
10.9 Lightbeam Health Solutions
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:
10.9.2.2 Acquisition and Mergers:
10.10. Reveleer
10.10.1 Company Overview
10.10.2 Recent strategies and developments:
10.10.2.1 Acquisition and Mergers:
List of Tables
TABLE 1 North America Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 2 North America Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Enterprise Key Management Market
TABLE 4 Product Launches And Product Expansions– Enterprise Key Management Market
TABLE 5 Acquisition and Mergers– Enterprise Key Management Market
TABLE 6 North America Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 7 North America Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 8 North America Software Market by Region, 2020 - 2023, USD Million
TABLE 9 North America Software Market by Region, 2024 - 2031, USD Million
TABLE 10 North America Services Market by Region, 2020 - 2023, USD Million
TABLE 11 North America Services Market by Region, 2024 - 2031, USD Million
TABLE 12 North America Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 13 North America Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 14 North America Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 15 North America Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 16 North America Ambulatory Surgical Centers Market by Country, 2020 - 2023, USD Million
TABLE 17 North America Ambulatory Surgical Centers Market by Country, 2024 - 2031, USD Million
TABLE 18 North America Long Term Care Centers Market by Country, 2020 - 2023, USD Million
TABLE 19 North America Long Term Care Centers Market by Country, 2024 - 2031, USD Million
TABLE 20 North America Other Market by Country, 2020 - 2023, USD Million
TABLE 21 North America Other Market by Country, 2024 - 2031, USD Million
TABLE 22 North America Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 23 North America Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 24 North America Private Cloud Market by Country, 2020 - 2023, USD Million
TABLE 25 North America Private Cloud Market by Country, 2024 - 2031, USD Million
TABLE 26 North America Public Cloud Market by Country, 2020 - 2023, USD Million
TABLE 27 North America Public Cloud Market by Country, 2024 - 2031, USD Million
TABLE 28 North America Hybrid Cloud Market by Country, 2020 - 2023, USD Million
TABLE 29 North America Hybrid Cloud Market by Country, 2024 - 2031, USD Million
TABLE 30 North America Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 31 North America Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 32 North America Population Health Management Market by Country, 2020 - 2023, USD Million
TABLE 33 North America Population Health Management Market by Country, 2024 - 2031, USD Million
TABLE 34 North America Chronic Disease Management Market by Country, 2020 - 2023, USD Million
TABLE 35 North America Chronic Disease Management Market by Country, 2024 - 2031, USD Million
TABLE 36 North America Clinical Decision Support Market by Country, 2020 - 2023, USD Million
TABLE 37 North America Clinical Decision Support Market by Country, 2024 - 2031, USD Million
TABLE 38 North America Fraud Detection and Prevention Market by Country, 2020 - 2023, USD Million
TABLE 39 North America Fraud Detection and Prevention Market by Country, 2024 - 2031, USD Million
TABLE 40 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 41 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 42 North America Clinical Risk Grouping Solution Market by Country, 2020 - 2023, USD Million
TABLE 43 North America Clinical Risk Grouping Solution Market by Country, 2024 - 2031, USD Million
TABLE 44 US Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 45 US Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 46 US Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 47 US Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 48 US Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 49 US Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 50 US Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 51 US Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 52 US Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 53 US Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 54 Canada Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 55 Canada Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 56 Canada Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 57 Canada Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 58 Canada Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 59 Canada Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 60 Canada Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 61 Canada Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 62 Canada Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 63 Canada Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 64 Mexico Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 65 Mexico Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 66 Mexico Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 67 Mexico Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 68 Mexico Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 69 Mexico Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 70 Mexico Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 71 Mexico Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 72 Mexico Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 73 Mexico Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 74 Rest of North America Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 75 Rest of North America Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 76 Rest of North America Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 77 Rest of North America Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 78 Rest of North America Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 79 Rest of North America Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 80 Rest of North America Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 81 Rest of North America Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 82 Rest of North America Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 83 Rest of North America Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 84 Key Information –Conduent, Incorporated
TABLE 85 Key Information – 3M Company
TABLE 86 Key Information – Oracle Corporation
TABLE 87 Key Information – Microsoft Corporation
TABLE 88 Key Information – Health Catalyst, Inc.
TABLE 89 Key Information – Koninklijke Philips N.V.
TABLE 90 Key Information – Siemens Healthineers AG
TABLE 91 Key Information – HBI Solutions
TABLE 92 Key Information – Lightbeam Health Solutions
TABLE 93 Key Information – Reveleer
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Clinical Risk Grouping Solution Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting the Clinical Risk Grouping Solution Market
FIG 4 KBV Cardinal Matrix
FIG 5 Market Share Analysis, 2023
FIG 6 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 7 Key Strategic Move: (Product Launches and Product Expansions : 2021, Mar – 2024, Apr) Leading Players
FIG 8 Porter’s Five Forces Analysis – Clinical Risk Grouping Solution Market
FIG 9 North America Clinical Risk Grouping Solution Market Share by Product, 2023
FIG 10 North America Clinical Risk Grouping Solution Market Share by Product, 2031
FIG 11 North America Clinical Risk Grouping Solution Market by Product, 2020 - 2031, USD Million
FIG 12 North America Clinical Risk Grouping Solution Market Share by End-use, 2023
FIG 13 North America Clinical Risk Grouping Solution Market Share by End-use, 2031
FIG 14 North America Clinical Risk Grouping Solution Market by End-use, 2020 - 2031, USD Million
FIG 15 North America Clinical Risk Grouping Solution Market Share by Deployment, 2023
FIG 16 North America Clinical Risk Grouping Solution Market Share by Deployment, 2031
FIG 17 North America Clinical Risk Grouping Solution Market by Deployment, 2020 - 2031, USD Million
FIG 18 North America Clinical Risk Grouping Solution Market Share by Application, 2023
FIG 19 North America Clinical Risk Grouping Solution Market Share by Application, 2031
FIG 20 North America Clinical Risk Grouping Solution Market by Application, 2020 - 2031, USD Million
FIG 21 North America Clinical Risk Grouping Solution Market Share by Country, 2023
FIG 22 North America Clinical Risk Grouping Solution Market Share by Country, 2031
FIG 23 North America Clinical Risk Grouping Solution Market by Country, 2020 - 2031, USD Million
FIG 24 SWOT Analysis: 3M Company
FIG 25 SWOT Analysis: Oracle Corporation
FIG 26 SWOT Analysis: Microsoft Corporation
FIG 27 Recent strategies and developments: Health Catalyst, INc.
FIG 28 Swot Analysis: Health Catalyst, INc.
FIG 29 Recent strategies and developments: Koninklijke Philips N.V.
FIG 30 SWOT Analysis: Koninklijke Philips N.V.
FIG 31 SWOT Analysis: Siemens Healthineers AG
FIG 32 Recent strategies and developments: Lightbeam Health Solutions
TABLE 2 North America Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Enterprise Key Management Market
TABLE 4 Product Launches And Product Expansions– Enterprise Key Management Market
TABLE 5 Acquisition and Mergers– Enterprise Key Management Market
TABLE 6 North America Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 7 North America Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 8 North America Software Market by Region, 2020 - 2023, USD Million
TABLE 9 North America Software Market by Region, 2024 - 2031, USD Million
TABLE 10 North America Services Market by Region, 2020 - 2023, USD Million
TABLE 11 North America Services Market by Region, 2024 - 2031, USD Million
TABLE 12 North America Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 13 North America Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 14 North America Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 15 North America Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 16 North America Ambulatory Surgical Centers Market by Country, 2020 - 2023, USD Million
TABLE 17 North America Ambulatory Surgical Centers Market by Country, 2024 - 2031, USD Million
TABLE 18 North America Long Term Care Centers Market by Country, 2020 - 2023, USD Million
TABLE 19 North America Long Term Care Centers Market by Country, 2024 - 2031, USD Million
TABLE 20 North America Other Market by Country, 2020 - 2023, USD Million
TABLE 21 North America Other Market by Country, 2024 - 2031, USD Million
TABLE 22 North America Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 23 North America Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 24 North America Private Cloud Market by Country, 2020 - 2023, USD Million
TABLE 25 North America Private Cloud Market by Country, 2024 - 2031, USD Million
TABLE 26 North America Public Cloud Market by Country, 2020 - 2023, USD Million
TABLE 27 North America Public Cloud Market by Country, 2024 - 2031, USD Million
TABLE 28 North America Hybrid Cloud Market by Country, 2020 - 2023, USD Million
TABLE 29 North America Hybrid Cloud Market by Country, 2024 - 2031, USD Million
TABLE 30 North America Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 31 North America Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 32 North America Population Health Management Market by Country, 2020 - 2023, USD Million
TABLE 33 North America Population Health Management Market by Country, 2024 - 2031, USD Million
TABLE 34 North America Chronic Disease Management Market by Country, 2020 - 2023, USD Million
TABLE 35 North America Chronic Disease Management Market by Country, 2024 - 2031, USD Million
TABLE 36 North America Clinical Decision Support Market by Country, 2020 - 2023, USD Million
TABLE 37 North America Clinical Decision Support Market by Country, 2024 - 2031, USD Million
TABLE 38 North America Fraud Detection and Prevention Market by Country, 2020 - 2023, USD Million
TABLE 39 North America Fraud Detection and Prevention Market by Country, 2024 - 2031, USD Million
TABLE 40 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 41 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 42 North America Clinical Risk Grouping Solution Market by Country, 2020 - 2023, USD Million
TABLE 43 North America Clinical Risk Grouping Solution Market by Country, 2024 - 2031, USD Million
TABLE 44 US Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 45 US Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 46 US Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 47 US Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 48 US Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 49 US Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 50 US Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 51 US Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 52 US Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 53 US Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 54 Canada Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 55 Canada Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 56 Canada Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 57 Canada Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 58 Canada Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 59 Canada Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 60 Canada Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 61 Canada Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 62 Canada Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 63 Canada Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 64 Mexico Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 65 Mexico Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 66 Mexico Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 67 Mexico Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 68 Mexico Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 69 Mexico Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 70 Mexico Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 71 Mexico Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 72 Mexico Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 73 Mexico Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 74 Rest of North America Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
TABLE 75 Rest of North America Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
TABLE 76 Rest of North America Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
TABLE 77 Rest of North America Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
TABLE 78 Rest of North America Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
TABLE 79 Rest of North America Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
TABLE 80 Rest of North America Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
TABLE 81 Rest of North America Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
TABLE 82 Rest of North America Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
TABLE 83 Rest of North America Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
TABLE 84 Key Information –Conduent, Incorporated
TABLE 85 Key Information – 3M Company
TABLE 86 Key Information – Oracle Corporation
TABLE 87 Key Information – Microsoft Corporation
TABLE 88 Key Information – Health Catalyst, Inc.
TABLE 89 Key Information – Koninklijke Philips N.V.
TABLE 90 Key Information – Siemens Healthineers AG
TABLE 91 Key Information – HBI Solutions
TABLE 92 Key Information – Lightbeam Health Solutions
TABLE 93 Key Information – Reveleer
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Clinical Risk Grouping Solution Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting the Clinical Risk Grouping Solution Market
FIG 4 KBV Cardinal Matrix
FIG 5 Market Share Analysis, 2023
FIG 6 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 7 Key Strategic Move: (Product Launches and Product Expansions : 2021, Mar – 2024, Apr) Leading Players
FIG 8 Porter’s Five Forces Analysis – Clinical Risk Grouping Solution Market
FIG 9 North America Clinical Risk Grouping Solution Market Share by Product, 2023
FIG 10 North America Clinical Risk Grouping Solution Market Share by Product, 2031
FIG 11 North America Clinical Risk Grouping Solution Market by Product, 2020 - 2031, USD Million
FIG 12 North America Clinical Risk Grouping Solution Market Share by End-use, 2023
FIG 13 North America Clinical Risk Grouping Solution Market Share by End-use, 2031
FIG 14 North America Clinical Risk Grouping Solution Market by End-use, 2020 - 2031, USD Million
FIG 15 North America Clinical Risk Grouping Solution Market Share by Deployment, 2023
FIG 16 North America Clinical Risk Grouping Solution Market Share by Deployment, 2031
FIG 17 North America Clinical Risk Grouping Solution Market by Deployment, 2020 - 2031, USD Million
FIG 18 North America Clinical Risk Grouping Solution Market Share by Application, 2023
FIG 19 North America Clinical Risk Grouping Solution Market Share by Application, 2031
FIG 20 North America Clinical Risk Grouping Solution Market by Application, 2020 - 2031, USD Million
FIG 21 North America Clinical Risk Grouping Solution Market Share by Country, 2023
FIG 22 North America Clinical Risk Grouping Solution Market Share by Country, 2031
FIG 23 North America Clinical Risk Grouping Solution Market by Country, 2020 - 2031, USD Million
FIG 24 SWOT Analysis: 3M Company
FIG 25 SWOT Analysis: Oracle Corporation
FIG 26 SWOT Analysis: Microsoft Corporation
FIG 27 Recent strategies and developments: Health Catalyst, INc.
FIG 28 Swot Analysis: Health Catalyst, INc.
FIG 29 Recent strategies and developments: Koninklijke Philips N.V.
FIG 30 SWOT Analysis: Koninklijke Philips N.V.
FIG 31 SWOT Analysis: Siemens Healthineers AG
FIG 32 Recent strategies and developments: Lightbeam Health Solutions